Ceramides and their interactive effects with trimethylamine-N-oxide metabolites on risk of gestational diabetes: A nested case-control study
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 171, 108606
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- National Key Research and Development Program of China
This publication has 34 references indexed in Scilit:
- Ceramide: A simple sphingolipid with unique biophysical propertiesProgress in Lipid Research, 2014
- Role of ceramide in diabetes mellitus: evidence and mechanismsLipids in Health and Disease, 2013
- Ablation of Very Long Acyl Chain Sphingolipids Causes Hepatic Insulin Resistance in Mice Due to Altered Detergent-Resistant MembranesHepatology, 2012
- Gestational diabetes mellitus: risks and management during and after pregnancyNature Reviews Endocrinology, 2012
- Chain length-specific properties of ceramidesProgress in Lipid Research, 2012
- International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in PregnancyDiabetes Care, 2010
- Blockage of ceramide metabolism exacerbates palmitate inhibition of pro-insulin gene expression in pancreatic β-cellsMolecular and Cellular Biochemistry, 2010
- Ceramide is the key mediator of oxidative stress‐induced apoptosis in retinal photoreceptor cellsJournal of Neurochemistry, 2006
- Calculating measures of biological interactionEuropean Journal of Epidemiology, 2005
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004